Heart Failure

Blood Pressure Paradox: Hypertension Associated with Survival in T2D and HFPatients with comorbid T2D and heart failure may have a "distinct pathophysiology of the heart" say authors of a new study.
SGLT2 Inhibitors Improve HF, Survival in Clinical T2D PopulationFindings from the REAL-CVD outcomes study reported at ACC.17 suggest class effect for cardioprotection.
FOURIER Clinical Outcomes Trial Results: Center Stage at ACC.17Highly anticipated, the 2-year results support the promise of PCSK9 inhibitors and also highlight important questions.
Hypertension Management Complicated by Hyperkalemia: What's your Rx?Case-based quiz: Test your clinical judgement on optimal hypertension therapy for this complex patient at risk for hyperkalemia.
Moderate Exercise Still Standard vs High-intensity Routine in Chronic HFSMARTEX HF is first multicenter RCT to evaluate high intensity interval training in patients with HFrEF
  • 1
  • 2